Effectiveness [qlco]
Low dose [qnco]
Crystalline [chvs]
Nicotinic Acid [orch, phsu, vita]
Men [popg]
low [qlco]
High density lipoprotein cholesterol level [lbpr]
Background [cnce]
Hypo alpha Lipoproteinemia [fndg]
low [qlco]
serum concentration [qnco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Common [qnco]
Pattern [spco]
Dyslipidaemia [dsyn]
Associated [qlco]
coronary heart disease [dsyn]
High dose [qnco]
Nicotinic Acid [orch, phsu, vita]
High density lipoprotein cholesterol level [lbpr]
condition [dsyn]
side effects [ftcn]
Efficacy [qlco]
Low dose [qnco]
Nicotinic Acid [orch, phsu, vita]
Few [qnco]
side effects [ftcn]
Not [ftcn]
Study [mnob]
Objective [inpr]
To [qlco]
effects [qlco]
Low dose [qnco]
Nicotinic Acid [orch, phsu, vita]
High density lipoprotein cholesterol level [lbpr]
Patients [podg]
Hypo alpha Lipoproteinemia [fndg]
Methods [inpr]
Four [qnco]
Men [popg]
Low density lipoprotein cholesterol level [lbpr]
High [qlco]
mmol/L [qnco]
mg dl [qnco]
Entered [qlco]
Study [mnob]
twenty [orch, phsu]
Four [qnco]
Patients [podg]
normal lipid [fndg]
Level [qlco]
Moderately [qlco]
Range [qnco]
Plasma triglyceride level [lbpr]
MMOLE [qnco]
mg dl [qnco]
Trial [resa]
Phase [tmco]
Last [qlco]
weeks [tmco]
First [qnco]
Phase [tmco]
Diet [food]
Only [qnco]
Fat diet [topp]
Second [qnco]
Phase [tmco]
Crystalline [chvs]
Nicotinic Acid [orch, phsu, vita]
Added [ftcn]
g d [qnco]
Third [qnco]
Phase [tmco]
Dose [qnco]
Increased [qnco]
g% [qnco]
Result [ftcn]
Patients [podg]
Entered [qlco]
Study [mnob]
COMPLETED [qlco]
Low dose [qnco]
Phase [tmco]
g d [qnco]
Remaining [qlco]
Patients [podg]
Withdrawn [fndg]
side effects [ftcn]
Nicotinic Acid [orch, phsu, vita]
Four [qnco]
Patients [podg]
COMPLETED [qlco]
Low dose [qnco]
Phase [tmco]
Excluded [idcn]
High dose [qnco]
Phase [tmco]
side effects [ftcn]
Receive [qlco]
Low dose [qnco]
TEN [dsyn]
Patients [podg]
Withdraw [acty]
High dose [qnco]
Phase [tmco]
side effects [ftcn]
Group [idcn]
responses [orga]
Nicotinic Acid [orch, phsu, vita]
therapy [ftcn]
To [qlco]
Dose-dependent [qnco]
Group [idcn]
High dose [qnco]
reduction [npop]
Apolipoprotein B [aapp, bacs]
Containing [ftcn]
Lipoproteins [aapp, bacs]
High density lipoprotein cholesterol level [lbpr]
Group [idcn]
Low dose [qnco]
Nicotinic Acid [orch, phsu, vita]
Give [ftcn]
Average [qnco]
Increase [ftcn]
High density lipoprotein cholesterol level [lbpr]
Conclusions [idcn]
Low dose [qnco]
g d [qnco]
Crystalline [chvs]
Nicotinic Acid [orch, phsu, vita]
Average [qnco]
Increase [ftcn]
High density lipoprotein cholesterol level [lbpr]
Lower [spco]
Triglyceride level [lbtr]
Patients [podg]
Low density lipoprotein cholesterol level [lbpr]
High [qlco]
Induced [ftcn]
Dose [qnco]
High dose [qnco]
Low dose [qnco]
Better [qlco]
Nicotinic Acid [orch, phsu, vita]
Combined therapy [topp]
Drug [phsu]
Secondary Prevention [topp]
coronary heart disease [dsyn]
If [qlco]
High dose [qnco]
Low dose [qnco]
Moderate [qlco]
High density lipoprotein cholesterol level [lbpr]
Patients [podg]
Hypo alpha Lipoproteinemia [fndg]
